This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA276451; GEO: GSE66298 |
| Type | Umbrella project |
| Publications | Mohammad HP et al., "A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.", Cancer Cell, 2015 Jul 13;28(1):57-69 |
| Submission | Registration date: 25-Feb-2015
GlaxoSmithKline |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 6 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 6 |
| GEO DataSets | 4 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 25205634 |
| Data volume, Processed Mbytes | 556 |
| Data volume, Supplementary Mbytes | 1846 |
| Parameter | Value |
|---|
| Data volume, Gbases | 8 |
| Data volume, Mbytes | 4884 |
This project encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA276452 | Homo sapiens | A DNA Hypomethylation Signature Predicts Novel Anti-Tumor Activity of LSD1 Inhibitors in SCLC (BeadChip) (GlaxoSmithKline) | | PRJNA276457 | Homo sapiens | A DNA Hypomethylation Signature Predicts Novel Anti-Tumor Activity of LSD1 Inhibitors in SCLC (ChIP-Seq) (GlaxoSmithKline) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA276453 | Homo sapiens | A DNA Hypomethylation Signature Predicts Novel Anti-Tumor Activity of LSD1 Inhibitors in SCLC (microarray) (GlaxoSmithKline) |
|